Portage Biotech Stock Alpha and Beta Analysis
| PRTG Stock | USD 4.87 0.15 3.18% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Portage Biotech. It also helps investors analyze the systematic and unsystematic risks associated with investing in Portage Biotech over a specified time horizon. Remember, high Portage Biotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Portage Biotech's market risk premium analysis include:
Beta (1.12) | Alpha 0.83 | Risk 17.36 | Sharpe Ratio 0.065 | Expected Return 1.13 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Portage |
Portage Biotech Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Portage Biotech market risk premium is the additional return an investor will receive from holding Portage Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Portage Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Portage Biotech's performance over market.| α | 0.83 | β | -1.12 |
Portage Biotech expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Portage Biotech's Buy-and-hold return. Our buy-and-hold chart shows how Portage Biotech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Portage Biotech Market Price Analysis
Market price analysis indicators help investors to evaluate how Portage Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Portage Biotech shares will generate the highest return on investment. By understating and applying Portage Biotech stock market price indicators, traders can identify Portage Biotech position entry and exit signals to maximize returns.
Portage Biotech Return and Market Media
The median price of Portage Biotech for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 is 5.58 with a coefficient of variation of 28.43. The daily time series for the period is distributed with a sample standard deviation of 1.56, arithmetic mean of 5.5, and mean deviation of 1.25. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Wall Street Lower Ahead Of Interest Rate Move | 09/18/2024 |
2 | Where are the Opportunities in - Stock Traders Daily | 10/07/2024 |
About Portage Biotech Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Portage or other stocks. Alpha measures the amount that position in Portage Biotech has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Graham Number | 4.06 | 3.86 | Receivables Turnover | 1.06 | 1.01 |
Portage Biotech Upcoming Company Events
As portrayed in its financial statements, the presentation of Portage Biotech's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Portage Biotech's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Portage Biotech's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Portage Biotech. Please utilize our Beneish M Score to check the likelihood of Portage Biotech's management manipulating its earnings.
| 6th of March 2024 Upcoming Quarterly Report | View | |
| 29th of July 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of July 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Build Portfolio with Portage Biotech
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Portage Biotech Backtesting, Portage Biotech Valuation, Portage Biotech Correlation, Portage Biotech Hype Analysis, Portage Biotech Volatility, Portage Biotech History and analyze Portage Biotech Performance. For more detail on how to invest in Portage Stock please use our How to Invest in Portage Biotech guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Portage Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.